Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8+ T Cells
Jefte M. Drijvers(Brigham and Women's Hospital), Arlene H. Sharpe(Broad Institute)
Cited by 169
Related Papers
PD-1 and Its Ligands in Tolerance and Immunity
|Annual Review of Immunology|2008|5.3k
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
|The Journal of Experimental Medicine|2009|2k
PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
|The Journal of Experimental Medicine|2017|872
A CRISPR-Cas9 delivery system for in vivo screening of genes in the immune system
|Nature Communications|2019|117
Formate Supplementation Enhances Antitumor CD8+ T-cell Fitness and Efficacy of PD-1 Blockade
|Cancer Discovery|2023|48